 Thrombin tumor-platelet adhesion vitro metastasis vivo Recent studies role platelets platelet-adhesive proteins fibronectin von Willebrand factor vWF platelet-tumor cell interaction vitro metastasis vivo present report documents effect thrombin treatment platelets interaction vitro vivo vitro thrombin mU/ml adhesion different tumor cell lines different species little mU/ml effective effect thrombin specific inhibitable hirudin dansyl-arginine N- pentanediyl amide unreactive inactive thrombin analogue N-P-tosyl-L-phenylchloromethylketone-thrombin D-phenylalanyl-L-propyl-L-arginine chloromethylketone-thrombin PPACK-thrombin high-affinity thrombin receptors competition PPACK-thrombin N-P-tosyl-L-lysine-chloromethyl-ketone-thrombin active thrombin platelet surface Binding tumor cells thrombin-activated platelets inhibitable agents platelet GPIIb-GPIIIa integrin monoclonal antibody tetrapeptide RGDS gamma chain fibrinogen decapeptide LGGAKQAGDV polyclonal antibodies platelet adhesive ligands fibronectin vWF vivo thrombin mU animal murine pulmonary metastases colon carcinoma cells amelanotic melanoma cells thrombin amplifies tumor-platelet adhesion vitro two- occupancy high-affinity platelet thrombin receptors modulation GPIIb-GPIIIa adhesion RGD-dependent mechanism vivo thrombin enhances tumor different tumor cell lines